Cystinuria News
Teva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tablets
Teva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tablets TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries [...]
α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases
α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases Cystinuria is an autosomal recessive disorder characterized by excessive urinary excretion of cystine, resulting in recurrent cystine kidney [...]
Grateful parents in 150km Christmas charity challenge to say thank you for son’s care
A grateful couple are undertaking a Christmas charity challenge to say thank you to a hospital that provided care for their son. By Stephanie Bateman Wednesday, 16th December 2020, 11:57 am NOTE: [...]
2020 – Update on cystine stones: current and future concepts in treatment
2020 - Update on cystine stones: current and future concepts in treatment Visit the IRDR site and original article here Download PDF Here Summary Cystine stones are relatively uncommon compared [...]
Dr Goldfarb on Corona Virus
Coronavirus News: COVID-19 increases urgency for Tablo Hemodialysis Systems "We think 30% of ICU patients are developing acute kidney injury," said Dr. David Goldfarb, Chief of Nephrology at New York [...]
New Formulation of Tiopronin Receives FDA Approval for Treatment of Cystinuria
New Formulation of Tiopronin Receives FDA Approval for Treatment of Cystinuria Officials with the FDA have approved a new enteric-coated formulation of tiopronin (Thiola EC, Retrophin) 100 mg and 300 [...]
α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases
α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases A recent study revealed efficacy of nutritional supplement α-lipoic acid (ALA) treatment in preventing kidney stones in a [...]
Retrophin Announces FDA Approval of THIOLA® EC (tiopronin) 100mg and 300mg Tablets
Retrophin Announces FDA Approval of THIOLA® EC (tiopronin) 100mg and 300mg Tablets Retrophin, Inc. (NASDAQ: RTRX) today announced that the U.S. Food and Drug Administration (FDA) has approved 100 mg and [...]